Jade Biosciences, Inc.
USD21.79
-0.32 (-1.45%)
CEO
Tom Frohlich
IPO Date
2025-04-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$22.08
Prev. Close
$22.11
Day Low
$21.57
Day High
$22.82
52W Low
$6.67
52W High
$28.00
Market Cap
$0.71B
Volume
0.02M
| $0.00 |
| 11 Jun 2026 | CAIN CHRISTOPHER W. | director | A-Award | Acquired | 34,843 | $15.22 |
| 11 Jun 2026 | DOBMEIER ERIC | director | A-Award | Acquired | 34,843 | $15.22 |
| 11 Jun 2026 | Klein Lawrence Otto | director | A-Award | Acquired | 34,843 | $15.22 |
| 11 Jun 2026 | Lavelle Erin | director | A-Award | Acquired | 34,843 | $15.22 |
| 11 Jun 2026 | Fairmount Funds Management LLC | director, 10 percent owner: | A-Award | Acquired | 34,843 | $15.22 |
| 13 Feb 2026 | Dahms Bradford D. | Chief Financial Officer | A-Award | Acquired | 37,813 | $0.00 |
| 13 Feb 2026 | Dahms Bradford D. | Chief Financial Officer | A-Award | Acquired | 226,875 | $14.81 |
| 13 Feb 2026 | Balta Elizabeth | See Remarks | A-Award | Acquired | 168,750 | $14.81 |